Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon and Citicoline for Delirium
NCT02840591Phase 4Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramelteon, citicoline in delirium, sponsored by UT Southwestern Medical Center. Planned start Jul 2016; status: withdrawn.
02
Drugs
ramelteonciticoline
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02840591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840591.